Citation Impact
Citing Papers
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
2020 StandoutScience
Cell entry mechanisms of SARS-CoV-2
2020 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Excellent Safety and Tolerability of the Human Immunodeficiency Virus Type 1 pGA2/JS2 Plasmid DNA Priming Vector Vaccine in HIV Type 1 Uninfected Adults
2006
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
2009 StandoutNobel
Origin and evolution of pathogenic coronaviruses
2018 Standout
The March Toward Malaria Vaccines
2015
Plasmodium vivax and Mixed Infections Are Associated with Severe Malaria in Children: A Prospective Cohort Study from Papua New Guinea
2008
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
2017
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
2017
Characteristics of SARS-CoV-2 and COVID-19
2020 Standout
Syphilis
2016 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
A guide to vaccinology: from basic principles to new developments
2020
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
2020 Standout
Virus-like particles in vaccine development
2010
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
2009
Mucosal immunity and vaccines
2005 Standout
Bacteria as DNA vaccine carriers for genetic immunization
2004
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Vaccine Adjuvants: Putting Innate Immunity to Work
2010
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
Malaria
2013 Standout
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
A Human Challenge Model for Mycobacterium tuberculosis Using Mycobacterium bovis Bacille Calmette-Guérin
2012
Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates
2019
Improving transparency and reproducibility through registration: The status of intervention trials published in clinical psychology journals.
2016
Pre-erythrocytic malaria vaccines: towards greater efficacy
2005
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Viral vectors for malaria vaccine development
2006
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
2020 Standout
Antibiotic resistance in the environment
2021 Standout
Pre-erythrocytic malaria vaccines: identifying the targets
2012
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
2019
Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates
2010 StandoutNobel
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
2020 StandoutNature
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
2020 Standout
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Meta‐analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine‐related issues
2009
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Human Clinical Trials of Plasmid DNA Vaccines
2005
Helminth infections: the great neglected tropical diseases
2008 Standout
Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii
2010 StandoutNobel
Control of Neglected Tropical Diseases
2007 Standout
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
Induction of long‐lasting multi‐specific CD8+ T cells by a four‐component DNA‐MVA/HIVA‐RENTA candidate HIV‐1 vaccine in rhesus macaques
2006
Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection
2008
Worms can worsen malaria: towards a new means to roll back malaria?
2005
SARS-CoV-2 vaccines in development
2020 StandoutNature
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
A Serological Point-of-Care Test for the Detection of IgG Antibodies against Ebola Virus in Human Survivors
2018
Induction of Plasmodium falciparum Transmission-Blocking Antibodies in Nonhuman Primates by a Combination of DNA and Protein Immunizations
2003
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Vaccinology in the era of high-throughput biology
2015
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
2017
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
Application of Mycobacterial Proteomics to Vaccine Design: Improved Protection by Mycobacterium bovis BCG Prime-Rv3407 DNA Boost Vaccination against Tuberculosis
2004
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults
2016
Diagnosing COVID-19: The Disease and Tools for Detection
2020 Standout
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015
2016
Human Papillomavirus and Cervical Cancer
2003 Standout
Peptide Vaccine: Progress and Challenges
2014
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
DNA Vaccines: Progress and Challenges
2005
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
2020 StandoutScience
Yellow fever 17D as a vaccine vector for microbial CTL epitopes
2005 StandoutNobel
Young Lives Lost as B Cells Falter: What We Are Learning About Antibody Responses in Malaria
2013
The preregistration revolution
2018 Standout
DNA vaccines: an historical perspective and view to the future
2010
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
2020
Prospects for Malaria Vaccines: Pre-Erythrocytic Stages, Blood Stages, and Transmission-Blocking Stages
2019
Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms
2019
A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3
2008
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later
2020
B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
2021 StandoutNobel
Staphylococcal Biofilms: Challenges and Novel Therapeutic Perspectives
2021
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Posttranslational Modification of RecombinantPlasmodium falciparumApical Membrane Antigen 1: Impact on Functional Immune Responses to a Malaria Vaccine Candidate
2005
Pre-Erythrocytic Vaccines against Malaria
2020
Rapid development and deployment of high‐volume vaccines for pandemic response
2020
Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
2012 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
The Continuing Challenges of Leprosy
2006 Standout
Works of Vasee Moorthy being referenced
Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
2009
A review of malaria vaccine clinical projects based on the WHO rainbow table
2012
A Randomised, Double-Blind, Controlled Vaccine Efficacy Trial of DNA/MVA ME-TRAP Against Malaria Infection in Gambian Adults
2004
Malaria vaccine developments
2004
A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation
2016
Synergistic DNA–MVA prime-boost vaccination regimes for malaria and tuberculosis
2005
Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers
2003
On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014–2016 Ebola epidemic in West Africa
2016
Rationale for WHO's New Position Calling for Prompt Reporting and Public Disclosure of Interventional Clinical Trial Results
2015
Status of vaccine research and development of vaccines for Staphylococcus aureus
2016
The drugs don't work: WHO's role in advancing new antibiotics
2018
Experimental human challenge infections can accelerate clinical malaria vaccine development
2010
Measurement of malaria vaccine efficacy in phase III trials: Report of a WHO consultation
2007
MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials—Scientific, regulatory and public health perspectives
2008
The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps
2016
Safety and Immunogenicity of DNA/Modified Vaccinia Virus Ankara Malaria Vaccination in African Adults
2003
Design, recruitment, and microbiological considerations in human challenge studies
2015
WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016
2016
Phase 1 Evaluation of 3 Highly Immunogenic Prime‐Boost Regimens, Including a 12‐Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men
2004
Durable Human Memory T Cells Quantifiable by Cultured Enzyme-Linked Immunospot Assays Are Induced by Heterologous Prime Boost Immunization and Correlate with Protection against Malaria
2005
Ebola Vaccine — An Urgent International Priority
2014
Malaria vaccines: are we getting closer?
2007
DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
2000